Search results for "risk stratification"

showing 10 items of 71 documents

Primary Biliary Cholangitis management: controversies, perspectives, and daily practice implications from an expert panel

2020

Primary biliary cholangitis (PBC) is a rare progressive immune-mediated liver disease that, if not adequately treated, may culminate in end-stage disease and need for transplantation. According to current guidelines, PBC is diagnosed in the presence of antimitochondrial antibodies (AMA) or specific antinuclear antibodies, and of a cholestatic biochemical profile, while biopsy is recommended only in selected cases. All patients receive ursodeoxycholic acid (UDCA) in first line; the only registered second-line therapy is obeticholic acid (OCA) for UDCA-inadequate responders. Despite the recent advances in understanding PBC pathogenesis and developing new treatments, many grey areas remain. Si…

medicine.medical_specialtyPopulationReceptors Cytoplasmic and NuclearDiseaserisk stratificationfibrates; liver biopsy; management; obeticholic acid; primary biliary cholangitis; risk stratificationprimary biliary cholangitiBile Acids and Salts03 medical and health scienceschemistry.chemical_compoundLiver disease0302 clinical medicineobeticholic acidBiopsymedicineHumansIntensive care medicineeducationliver biopsyeducation.field_of_studyCholestasisfibrateHepatologymedicine.diagnostic_testbusiness.industryprimary biliary cholangitisLiver Cirrhosis BiliaryUrsodeoxycholic AcidObeticholic acidmedicine.diseaseUrsodeoxycholic acidBile Acids and SaltTransplantationchemistryCholestasi030220 oncology & carcinogenesisLiver biopsy030211 gastroenterology & hepatologyfibratesbusinessmanagementmedicine.drugHuman
researchProduct

New advances in radiomics of gastrointestinal stromal tumors

2020

Gastrointestinal stromal tumors (GISTs) are uncommon neoplasms of the gastrointestinal tract with peculiar clinical, genetic, and imaging characteristics. Preoperative knowledge of risk stratification and mutational status is crucial to guide the appropriate patients' treatment. Predicting the clinical behavior and biological aggressiveness of GISTs based on conventional computed tomography (CT) and magnetic resonance imaging (MRI) evaluation is challenging, unless the lesions have already metastasized at the time of diagnosis. Radiomics is emerging as a promising tool for the quantification of lesion heterogeneity on radiological images, extracting additional data that cannot be assessed b…

medicine.medical_specialtyStromal cellGastrointestinal Stromal TumorsComputed tomographyTexture analysis.Clinical applications03 medical and health sciences0302 clinical medicineMagnetic resonance imagingRadiomicsmedicineMutational statusHumansComputed tomographyGastrointestinal NeoplasmsRadiomicsmedicine.diagnostic_testbusiness.industryGastroenterologyMagnetic resonance imagingMinireviewsGeneral MedicinePrognosisClinical applicationClinical PracticeTexture analysis030220 oncology & carcinogenesisRisk stratification030211 gastroenterology & hepatologyRadiologyDifferential diagnosisGastrointestinal stromal tumorRadiomicbusinessTomography X-Ray Computed
researchProduct

Risk Stratification by nrTMS Language Mapping

2017

Resecting language-eloquent brain lesions is a major challenge in neurosurgery since we need to weight the risks of worsening the patients’ functional integrity and achieving a maximum safe resection. Although relevant functional brain structures can be identified intraoperatively by direct cortical mapping during awake surgery, a preoperative identification of functional anatomy is recommended in order to gauge surgical risks, evaluate resectability, plan the surgical approach, and identify potential starting points for intraoperative stimulation mapping.

medicine.medical_specialtySurgical approachbusiness.industryLanguage mapping03 medical and health sciencesFunctional integrityFunctional brain0302 clinical medicine030220 oncology & carcinogenesisFunctional anatomyRisk stratificationMedicineRadiologyNeurosurgerybusinessAwake surgery030217 neurology & neurosurgery
researchProduct

Risk stratification of normotensive pulmonary embolism based on the sPESI — Does it work for all patients?

2015

medicine.medical_specialtyWork (electrical)business.industryRisk stratificationMedicineCardiology and Cardiovascular MedicinebusinessIntensive care medicinemedicine.diseasePulmonary embolismInternational Journal of Cardiology
researchProduct

P6456Neopterin for risk stratification of patients with acute chest pain

2018

medicine.medical_specialtybusiness.industryInternal medicineRisk stratificationAcute chest painMedicineCardiology and Cardiovascular MedicinebusinessEuropean Heart Journal
researchProduct

Response to Letter Regarding Article, “The Inflammatory Hypothesis: Any Progress in Risk Stratification and Therapeutic Targets?”

2007

We thank Drs Ridker and Everett for their interest in our work,1 and we commend Ridker’s pioneering work describing an association between C-reactive protein (CRP) and the risk of myocardial infarction or stroke. Subsequent studies have both confirmed and refuted these original observations. The former studies “controlled” or “adjusted” for fewer other risk factors; when they did so, they dichotomized variables (a weaker approach) rather than using them as continuous variables. By contrast, the latter studies have incorporated adjustments for other markers (especially of abdominal obesity, because visceral fat …

medicine.medical_specialtybusiness.industrymedicine.diseaseSurgeryContinuous variablePhysiology (medical)Risk stratificationmedicineMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessIntensive care medicineStrokeVisceral fatAbdominal obesityCirculation
researchProduct

Treatment of patients with essential hypertension and microalbuminuria.

1998

There has been increasing interest in the question of whether microalbuminuria can be used in the risk stratification of patients with essential hypertension. A cluster of cardiovascular and/or renal risk factors may be associated with microalbuminuria in hypertension. Despite this, prospective data about the potential role of microalbuminuria as a prognostic marker of cardiovascular and/or renal risk have been sparse and inconclusive until now. Blood pressure values have been considered the most important determinant of microalbuminuria in essential hypertension; however, hyperinsulinaemia--a metabolic component-was noted to be present in conjunction with high blood pressure. Furthermore, …

medicine.medical_specialtyendocrine system diseasesbusiness.industrynutritional and metabolic diseasesProspective dataurologic and male genital diseasesmedicine.diseaseDisease clusterEssential hypertensionfemale genital diseases and pregnancy complicationsSurgeryPharmacotherapyFelodipineInternal medicineRisk stratificationHypertensionmedicineDoxazosinAlbuminuriaHumansPharmacology (medical)MicroalbuminuriabusinessAntihypertensive Agentsmedicine.drugDrugs
researchProduct

Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage

2006

With advances in imaging technology and our understanding of the role of inflammation in atherosclerosis, the macrophage appears to be an excellent target for imaging the progression of disease. In addition to imaging the macrophage with only 1 modality, contrast agents can be created that can be imaged with multiple modalities. This seems extremely attractive, as lesion morphology and characteristics can be determined with modalities that provide high picture resolution, such as CT or MRI, whereas macrophage quantity can be accurately determined through the creation of a radiolabeled contrast agent such as FDG via PET. Although this combination of imaging technologies may yield clinically …

medicine.medical_specialtymedia_common.quotation_subjectContrast MediaDiseaseModels BiologicalLesionFluorodeoxyglucose F18AnimalsHumansMedicineContrast (vision)MacrophageRadiology Nuclear Medicine and imagingRadionuclide Imagingmedia_commonModality (human–computer interaction)business.industryMacrophagesAtherosclerosisRisk stratificationImaging technologyRadiologyRadiopharmaceuticalsMolecular imagingmedicine.symptomCardiology and Cardiovascular MedicinebusinessJournal of Nuclear Cardiology
researchProduct

Hemithyroidectomy versus total thyroidectomy in the intermediate-risk differentiated thyroid cancer: the Italian Societies of Endocrine Surgeons and …

2021

The surgical treatment of the intermediate-risk DTC (1–4 cm) remains still controversial. We analyzed the current practice in Italy regarding the surgical management of intermediate-risk unilateral DTC to evaluate risk factors for recurrence and to identify a group of patients to whom propose a total thyroidectomy (TT) vs. hemithyroidectomy (HT). Among 1896 patients operated for thyroid cancer between January 2017 and December 2019, we evaluated 564 (29.7%) patients with unilateral intermediate-risk DTC (1–4 cm) without contralateral nodular lesions on the preoperative exams, chronic autoimmune thyroiditis, familiarity or radiance exposure. Data were collected retrospectively from the clini…

medicine.medical_specialtymedicine.medical_treatmentSettore MED/18 - CHIRURGIA GENERALEPapillaryDifferentiated thyroid carcinoma; Hemithyroidectomy; Intermediate-risk differentiated thyroid cancer; Risk stratification; Surgery; Thyroid; Humans; Italy; Neoplasm Recurrence Local; Retrospective Studies; Thyroidectomy; Carcinoma Papillary; Surgeons; Surgical Oncology; Thyroid NeoplasmsSurgeonSurgical oncologyRetrospective StudieHemithyroidectomymedicineHumansIntermediate-risk differentiated thyroid cancerThyroid NeoplasmsRisk factorThyroid cancerRisk stratificationRetrospective StudiesCompletion thyroidectomySurgeonsThyroidbusiness.industryThyroidCarcinomaThyroidectomyNeck dissectionRetrospective cohort studymedicine.diseaseCarcinoma PapillarySurgerymedicine.anatomical_structureNeoplasm RecurrenceSurgical OncologyLocalItalyDifferentiated thyroid carcinomaThyroidectomySurgeryNeoplasm Recurrence LocalbusinessHuman
researchProduct

Pulmonary Embolism: Contemporary Medical Management and Future Perspectives

2018

Pulmonary embolism (PE) contributes substantially to the global disease burden. A key determinant of early adverse outcomes is the presence (and severity) of right ventricular dysfunction. Consequently, risk-adapted management strategies continue to evolve, tailoring acute treatment to the patients' clinical presentation, hemodynamic status, imaging and biochemical markers, and comorbidity. For subjects with hemodynamic instability or 'high-risk' PE, immediate systemic reperfusion treatment with intravenous thrombolysis is indicated; emerging approaches such as catheter-directed pharmacomechanical reperfusion might help to minimize the bleeding risk. Currently, direct, non-vitamin K-depende…

medicine.medical_specialtythrombolysispulmonary embolismmedicine.medical_treatmentvenous thromboembolismHemodynamicsReview Articlerisk stratification030204 cardiovascular system & hematologyVitamin kdirect oral anticoagulants03 medical and health sciences0302 clinical medicinemedicine030212 general & internal medicineIntensive care medicineDisease burdenbusiness.industryGeneral MedicineThrombolysismedicine.diseaseComorbidityRight ventricular dysfunctionReview articlePulmonary embolismright ventricular dysfunctionbusinessAnnals of Vascular Diseases
researchProduct